Back
BioNTech SE Vs. Aligos Therapeutics Industry Stock Comparison
Sell
44
BNTX
BioNTech SE
Last Price:
$111.98
Seasonality Move:
4.91%
Sell
44
ALGS
Aligos Therapeutics
Last Price:
$34.15
Seasonality Move:
-27%
Sell
44
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy, Sell or Hold?
-
The current BioNTech SE [BNTX] share price is $111.93. The Score for BNTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
BNTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $34.24. The Score for ALGS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $111.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.24The current trend is relatively stagnant and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
BNTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 44.32 | Sell |
Chaikin Money Flow: | -457498 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.84 - 119.98) | Sell |
Bollinger Bands (100): | (102.16 - 121.44) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.91 | Buy |
Relative Strength Index (14 RSI): | 50.11 | Buy |
Chaikin Money Flow: | 205786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.96 - 41.26) | Sell |
Bollinger Bands (100): | (7.59 - 31.23) | Buy |
BNTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 117.05 | Sell |
20-day SMA: | 115.28 | Sell |
50-day SMA: | 113.99 | Sell |
200-day SMA: | 100.13 | Buy |
8-day EMA: | 114.79 | Sell |
20-day EMA: | 115.64 | Sell |
50-day EMA: | 114.36 | Sell |
200-day EMA: | 105.91 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.37 | Sell |
20-day SMA: | 37.9 | Sell |
50-day SMA: | 28.75 | Buy |
200-day SMA: | 17.48 | Buy |
8-day EMA: | 34.42 | Sell |
20-day EMA: | 35.21 | Sell |
50-day EMA: | 29.79 | Buy |
200-day EMA: | 20.62 | Buy |
BioNTech SE Earnings Growth & BNTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.10 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
BioNTech SE Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |